AMYLIN PHARMACEUTICALS, INC.
Patent Owner
Stats
- 32 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Aug 29, 2013 most recent publication
Details
- 32 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,215 Total Citation Count
- May 01, 1989 Earliest Filing
- 85 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2003/0087,820 Novel exendin agonist formulations and methods of administration thereofMay 28, 02May 08, 03[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8293871 Poly(lactide-co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugarApr 15, 05Oct 23, 12[A61K]
8026210 Exendins and exendin agonist analogs to regulate gastrointestinal motilityJan 14, 09Sep 27, 11[A61K]
7981861 Method of performing angioplasty with a GLP-1 moleculeJun 23, 10Jul 19, 11[A61K, A61P, C07K, A61M]
7928065 Methods of treatment using exendin peptides or GLP-1 peptidesOct 07, 08Apr 19, 11[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0225,485 Compositions and Methods for the Control, Prevention and Treatment of Obesity and Eating DisordersAbandonedSep 28, 12Aug 29, 13[A61K]
8501693 Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogenExpiredAug 06, 07Aug 06, 13[A61K]
2012/0294,855 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEAAbandonedOct 28, 10Nov 22, 12[A61K, A61P]
2012/0231,022 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENTAbandonedMay 27, 10Sep 13, 12[A61K, A61P]
2010/0323,955 METHODS FOR TREATING OBESITY AND OBESITY RELATED DISEASES AND DISORDERSAbandonedNov 14, 07Dec 23, 10[A61K, A61P]
2010/0168,011 Pharmaceutical Formulations and Methods for Making the SameAbandonedDec 11, 07Jul 01, 10[A61K, A61P]
2010/0125,054 Amylin and Amylin Agonists for Treating Psychiatric Diseases and DisordersAbandonedDec 18, 09May 20, 10[A61K, A61P]
7718400 Methods of increasing lean tissue mass using OB protein compositionsExpiredMar 16, 07May 18, 10[C07H, C12P, C12N, C07K]
2010/0009,907 Glucagon-Like Peptides and Uses ThereofAbandonedJul 06, 07Jan 14, 10[C07H, A61K, A61P, C07K]
2010/0004,166 Endothelin and Endothelin Receptor Agonists in the Treatment of Metabolic DiseasesAbandonedMar 23, 07Jan 07, 10[A61K, A61P]
2009/0239,796 METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHTAbandonedAug 18, 06Sep 24, 09[A61K, A61P]
2009/0209,469 Use of Exendins and GLP-1 Receptor Agonists for Altering Lipoprotein Particle Size and Subclass CompositionAbandonedAug 06, 07Aug 20, 09[A61K, A61P]
2009/0203,603 Compositions for the Treatment and Prevention of NephropathyAbandonedDec 18, 08Aug 13, 09[A61K]
2009/0186,817 PEPTIDE-PEPTIDASE INHIBITOR CONJUGATES AND METHODS OF USING SAMEAbandonedMar 21, 07Jul 23, 09[A61K, C07K]
7538182 Polypeptide and protein derivatives and process for their preparationExpiredSep 08, 06May 26, 09[A61K, C07K]
2009/0073,506 METHOD OF SETTING SCANNER-CONTROLLING INPUT SIGNAL AND DISPLAY APPARATUS APPLIED WITH THE SAMEAbandonedMar 25, 08Mar 19, 09[H04N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
